Home/Filings/4/0000947871-10-000975
4//SEC Filing

Usdan Adam 4

Accession 0000947871-10-000975

CIK 0001053369other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 5:52 PM ET

Size

15.6 KB

Accession

0000947871-10-000975

Insider Transaction Report

Form 4
Period: 2010-10-05
Transactions
  • Sale

    Common Stock

    2010-10-05$0.06/sh2,523$15122,739,955 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2010-10-06$0.06/sh24,000$1,44022,715,955 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2010-10-06$0.06/sh24,000$1,44022,715,955 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2010-10-05$0.06/sh2,523$15122,739,955 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2010-10-05$0.06/sh2,523$15122,739,955 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2010-10-06$0.06/sh24,000$1,44022,715,955 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2010-10-06$0.06/sh24,000$1,44022,715,955 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2010-10-05$0.06/sh2,523$15122,739,955 total(indirect: See Footnotes)
Usdan Adam
10% Owner
Transactions
  • Sale

    Common Stock

    2010-10-06$0.06/sh24,000$1,44022,715,955 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2010-10-05$0.06/sh2,523$15122,739,955 total(indirect: See Footnotes)
Footnotes (6)
  • [F1]On October 5, 2010, Trellus Partners, L.P., a Delaware limited partnership ("TPLP") sold 2,523 shares of Common Stock.
  • [F2]On October 5, 2010, following the reported transaction, TPLP owned 11,869,548 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and Trellus Offshore Fund Limited, a Cayman Islands limited liability company ("TOF") owned 6,002,344 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock and Trellus Partners, L.P. II ("TPLPII") owned 165,000 shares of Common Stock and warrants to acquire 33,879 shares of Common Stock. Trellus Management Company, LLC ("Trellus") and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF, and TPLPII.
  • [F3]Trellus is the investment adviser to TPLP, TOF, and TPLPII. Adam Usdan is the controlling principal and chief investment officer of Trellus. By reason of their investment discretion, Trellus and Mr. Usdan are reported herein as indirect beneficial owners of the securities described in this Form 4.
  • [F4]Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  • [F5]On October 6, 2010, TPLP sold 24,000 shares of Common Stock.
  • [F6]On October 6, 2010, following the reported transaction, TPLP owned 11,845,548 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,002,344 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock and TPLPII owned 165,000 shares of Common Stock and warrants to acquire 33,879 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF, and TPLPII.

Documents

1 file

Issuer

ELITE PHARMACEUTICALS INC /DE/

CIK 0001053369

Entity typeother

Related Parties

1
  • filerCIK 0001459107

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:52 PM ET
Size
15.6 KB